Therapy demonstrates activity of HBV-TCR-T cells in peripheral blood after liver transplantation, indicating potential benefits for recurrent HCC.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: